Weston Whitworth, OD - Medicare Optometrist in Shreveport, LA

Weston Whitworth, OD is a medicare enrolled "Optometrist" provider in Shreveport, Louisiana. His current practice location is 8889 Jewella Ave, Shreveport, Louisiana. You can reach out to his office (for appointments etc.) via phone at (318) 686-5227.

Weston Whitworth is licensed to practice in Louisiana (license number 1933-869AT) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1083284129.

Contact Information

Weston Whitworth, OD
8889 Jewella Ave,
Shreveport, LA 71118-2138
(318) 686-5227
Not Available



Healthcare Provider's Profile

Full NameWeston Whitworth
GenderMale
SpecialityOptometrist
Location8889 Jewella Ave, Shreveport, Louisiana
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1083284129
  • Provider Enumeration Date: 06/30/2021
  • Last Update Date: 07/14/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 6709267388
  • Enrollment ID: I20220713002391

Medical Identifiers

Medical identifiers for Weston Whitworth such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1083284129NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist 10284 (Texas)Secondary
390200000XStudent In An Organized Health Care Education/training Program (* (Not Available))Secondary
152W00000XOptometrist 1933-869AT (Louisiana)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Weston Whitworth allows following entities to bill medicare on his behalf.
Provider NameEye Central
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1386044808
PECOS PAC ID: 2365765658
Enrollment ID: O20141217000964

News Archive

AmpliPhi releases data on phage therapy for treatment of lung infections in Cystic Fibrosis patients

AmpliPhi BioSciences Corp. (OTC: APHB) ("AmpliPhi"), the leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant bacterial infections, yesterday presented data relating to the use of bacteriophages in the treatment of Pseudomonas aeruginosa (P. aeruginosa) at the 20th Biennial Evergreen International Phage Meeting held in Olympia, Washington, USA. P. aeruginosa is the major cause of lung infections in cystic fibrosis (CF) patients.

Embryos with two mums to remove the risk of hereditary diseases: new research

New research published in the journal Nature, could pave the way to world's first genetically modified human baby. The research involves making embryos with genes from one man and two women. There are hundreds or families around the world who are left childless or have serious ill babies because they carry genes for hereditary illnesses. This research may bring hope to such couples. According to scientists on the team, within the next three years these women will be able to avail such techniques. There has been skepticism regarding ethical issues attached to making of "designer babies".

Pharmaceutical companies say new approach by FDA has led to decrease approvals of new medications

An "intensifying focus on safety and a diminished tolerance for side effects" by FDA have "dramatically lowered" the chances that experimental medications will reach the market and have led to a recent decrease in approvals of new treatments, according to pharmaceutical companies, the Wall Street Journal reports.

Healthy heart may slow down aging of brain: Study

Keep your heart healthy and you may slow down the aging of your brain, according to a new study reported in Circulation: Journal of the American Heart Association.In the study, people whose hearts pumped less blood had brains that appeared older than the brains of those whose hearts pumped more blood. Decreased cardiac index, the amount of blood that pumps from the heart in relation to a person's body size, was associated with decreased brain volume using magnetic resonance imaging (MRI).

Advancing the development of a malaria transmission-blocking vaccine

Three leaders in malaria vaccine development announced today a collaboration to evaluate a potential vaccine candidate designed to prevent transmission of malaria from mosquitoes to humans—a type of vaccine that researchers think could contribute to the eventual eradication of malaria.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Weston Whitworth is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Weston Whitworth, OD
8889 Jewella Ave,
Shreveport, LA 71118-2138

Ph: (318) 686-5227
Weston Whitworth, OD
8889 Jewella Ave,
Shreveport, LA 71118-2138

Ph: (318) 686-5227

News Archive

AmpliPhi releases data on phage therapy for treatment of lung infections in Cystic Fibrosis patients

AmpliPhi BioSciences Corp. (OTC: APHB) ("AmpliPhi"), the leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant bacterial infections, yesterday presented data relating to the use of bacteriophages in the treatment of Pseudomonas aeruginosa (P. aeruginosa) at the 20th Biennial Evergreen International Phage Meeting held in Olympia, Washington, USA. P. aeruginosa is the major cause of lung infections in cystic fibrosis (CF) patients.

Embryos with two mums to remove the risk of hereditary diseases: new research

New research published in the journal Nature, could pave the way to world's first genetically modified human baby. The research involves making embryos with genes from one man and two women. There are hundreds or families around the world who are left childless or have serious ill babies because they carry genes for hereditary illnesses. This research may bring hope to such couples. According to scientists on the team, within the next three years these women will be able to avail such techniques. There has been skepticism regarding ethical issues attached to making of "designer babies".

Pharmaceutical companies say new approach by FDA has led to decrease approvals of new medications

An "intensifying focus on safety and a diminished tolerance for side effects" by FDA have "dramatically lowered" the chances that experimental medications will reach the market and have led to a recent decrease in approvals of new treatments, according to pharmaceutical companies, the Wall Street Journal reports.

Healthy heart may slow down aging of brain: Study

Keep your heart healthy and you may slow down the aging of your brain, according to a new study reported in Circulation: Journal of the American Heart Association.In the study, people whose hearts pumped less blood had brains that appeared older than the brains of those whose hearts pumped more blood. Decreased cardiac index, the amount of blood that pumps from the heart in relation to a person's body size, was associated with decreased brain volume using magnetic resonance imaging (MRI).

Advancing the development of a malaria transmission-blocking vaccine

Three leaders in malaria vaccine development announced today a collaboration to evaluate a potential vaccine candidate designed to prevent transmission of malaria from mosquitoes to humans—a type of vaccine that researchers think could contribute to the eventual eradication of malaria.

Read more News

› Verified 6 days ago


Optometrist in Shreveport, LA

Sam R Silverblatt, Od Apmc
Optometrist
Medicare: Medicare Enrolled
Practice Location: 1803 E 70th St, Shreveport, LA 71105
Phone: 318-798-4000    Fax: 318-798-4001
Dr. Christine M Davis, OD
Optometrist
Medicare: May Accept Medicare Assignments
Practice Location: 955 Pierremont Rd Ste 400, Shreveport, LA 71106
Phone: 318-868-6118    Fax: 318-666-9927
Look Eyecare Llc
Optometrist
Medicare: Medicare Enrolled
Practice Location: 5848 Line Ave, Shreveport, LA 71106
Phone: 318-865-0017    
Lusk Eye Specialists, Llc
Optometrist
Medicare: Medicare Enrolled
Practice Location: 451 Ashley Ridge Blvd, Shreveport, LA 71106
Phone: 318-222-5555    Fax: 318-222-6414
Dr. Bradly Kendall Larson, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 8889 Jewella Ave Ste C, Shreveport, LA 71118
Phone: 318-686-5227    Fax: 381-686-5283
Dr. Michael David Pickering, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 5848 Line Ave, Shreveport, LA 71106
Phone: 318-865-0017    Fax: 318-868-4738

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.